Last updated: 21 September 2023 at 1:36pm EST

Randall B. Brenner Net Worth




The estimated Net Worth of Randall B. Brenner is at least $1.63 Milhão dollars as of 8 August 2023. Mr Brenner owns over 27,603 units of Paratek Pharmaceuticals stock worth over $925,916 and over the last 5 years he sold PRTK stock worth over $703,895.

Mr Brenner PRTK stock SEC Form 4 insiders trading

Mr has made over 14 trades of the Paratek Pharmaceuticals stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 27,603 units of PRTK stock worth $60,727 on 8 August 2023.

The largest trade he's ever made was selling 29,282 units of Paratek Pharmaceuticals stock on 12 December 2022 worth over $57,686. On average, Mr trades about 9,456 units every 74 days since 2019. As of 8 August 2023 he still owns at least 415,209 units of Paratek Pharmaceuticals stock.

You can see the complete history of Mr Brenner stock trades at the bottom of the page.





Mr. Randall B. Brenner biography

Randall B. Brenner is the Chief Devel. & Regulatory Officer at Paratek Pharmaceuticals.



How old is Mr Brenner?

Mr Brenner is 48, he's been the Chief Devel. & Regulatory Officer of Paratek Pharmaceuticals since . There are 12 older and 3 younger executives at Paratek Pharmaceuticals. The oldest executive at Paratek Pharmaceuticals Inc. is Sergey Guz, 64, who is the Independent Director.

What's Mr Brenner's mailing address?

Randall's mailing address filed with the SEC is C/O PARATEK PHARMACEUTICALS, INC., 75 PARK PLAZA, 4TH FLOOR, BOSTON, MA, 02116.

Insiders trading at Paratek Pharmaceuticals

Over the last 10 years, insiders at Paratek Pharmaceuticals have traded over $9,410,794 worth of Paratek Pharmaceuticals stock and bought 1,743,576 units worth $13,751,429 . The most active insiders traders include James D Dondero, Bioventures Cayman Ltd Hbm, eEvan Loh. On average, Paratek Pharmaceuticals executives and independent directors trade stock every 24 days with the average trade being worth of $63,310. The most recent stock trade was executed by Randall B. Brenner on 8 August 2023, trading 27,603 units of PRTK stock currently worth $60,727.



What does Paratek Pharmaceuticals do?

paratek pharmaceuticals (nasdaq: prtk) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. we focus on drugs that target infectious disease and other difficult to treat conditions. our lead product candidate, omadacycline, is the first in a new class of tetracyclines known as aminomethycyclines, with broad spectrum activity against gram-positive, gram-negative and atypical bacteria. omadacycline is being developed as a once daily, oral and intravenous, empiric monotherapy for community acquired bacterial infections, particularly when antibiotic resistance is of concern. the food and drug administration (fda) granted omadacycline a qualified infectious disease product (qidp) designation and completed two special protocol assessments for its phase 3 clinical trial program.



What does Paratek Pharmaceuticals's logo look like?

Paratek Pharmaceuticals Inc. logo

Complete history of Mr Brenner stock trades at Paratek Pharmaceuticals

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
8 Aug 2023 Randall B. Brenner
Chief Development e Regulatory
Venda 27,603 $2.20 $60,727
8 Aug 2023
415,209
20 Dec 2022 Randall B. Brenner
Chief Development e Regulatory
Venda 4,539 $1.99 $9,033
20 Dec 2022
335,312
12 Dec 2022 Randall B. Brenner
Chief Development e Regulatory
Venda 29,282 $1.97 $57,686
12 Dec 2022
324,851
28 Oct 2022 Randall B. Brenner
Chief Development e Regulatory
Venda 3,516 $3.47 $12,201
28 Oct 2022
354,133
8 Aug 2022 Randall B. Brenner
Chief Development e Regulatory
Venda 19,608 $2.66 $52,157
8 Aug 2022
349,149
13 Dec 2021 Randall B. Brenner
Chief Development e Regulatory
Venda 27,894 $4.32 $120,502
13 Dec 2021
253,530
16 Aug 2021 Randall B. Brenner
Chief Development e Regulatory
Venda 8,766 $5.12 $44,882
16 Aug 2021
281,424
27 May 2021 Randall B. Brenner
Chief Development e Regulatory
Venda 9,978 $9.70 $96,787
27 May 2021
268,940
11 Dec 2020 Randall B. Brenner
Chief Development e Regulatory
Venda 14,924 $6.81 $101,632
11 Dec 2020
128,782
12 Nov 2020 Randall B. Brenner
Chief Development e Regulatory
Venda 8,357 $5.93 $49,557
12 Nov 2020
143,706
12 May 2020 Randall B. Brenner
Chief Development e Regulatory
Venda 6,198 $4.75 $29,441
12 May 2020
130,813
12 Dec 2019 Randall B. Brenner
Chief Development e Regulatory
Venda 6,278 $3.10 $19,462
12 Dec 2019
92,011
4 Oct 2019 Randall B. Brenner
Chief Development e Regulatory
Venda 5,049 $3.82 $19,287
4 Oct 2019
98,289
3 Oct 2019 Randall B. Brenner
Chief Development e Regulatory
Venda 7,674 $3.98 $30,543
3 Oct 2019
91,338


Paratek Pharmaceuticals executives and stock owners

Paratek Pharmaceuticals executives and other stock owners filed with the SEC include: